BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10586439)

  • 1. [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease].
    Marie I; Lévesque H; Dominique S; Hatron PY; Michon-Pasturel U; Remy-Jardin M; Courtois H
    Rev Med Interne; 1999 Nov; 20(11):1004-16. PubMed ID: 10586439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interstitial lung diseases in polymyositis and dermatomyositis].
    Marie I; Dominique S; Rémy-Jardin M; Hatron PY; Hachulla E
    Rev Med Interne; 2001 Nov; 22(11):1083-96. PubMed ID: 11817120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre.
    Beretta L; Caronni M; Raimondi M; Ponti A; Viscuso T; Origgi L; Scorza R
    Clin Rheumatol; 2007 Feb; 26(2):168-72. PubMed ID: 16614793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
    Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
    Sahhar J; Littlejohn G; Conron M
    Intern Med J; 2004 Nov; 34(11):626-38. PubMed ID: 15546457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of alveolitis and interstitial lung disease in scleroderma.
    Latsi PI; Wells AU
    Curr Opin Rheumatol; 2003 Nov; 15(6):748-55. PubMed ID: 14569205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung fibrosis in systemic sclerosis treated with a combination of ciclosporin and azathioprine.
    Hider SL; Woodhead M; Taylor PM; Bruce IN
    Clin Exp Rheumatol; 2006; 24(2):215. PubMed ID: 16762168
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessments of pulmonary involvement in patients with systemic sclerosis.
    Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
    Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study.
    Highland KB; Silver RM
    Curr Rheumatol Rep; 2005 Apr; 7(2):135-41. PubMed ID: 15760593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
    Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
    Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary involvement in systemic sclerosis].
    Ioanăş M
    Pneumologia; 2002; 51(3):230-3. PubMed ID: 12602096
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
    Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M
    Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic sclerosis].
    Schinke S; Riemekasten G
    Internist (Berl); 2019 Dec; 60(12):1251-1269. PubMed ID: 31754753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage].
    Marie I; Lévesque H; Hatron PY; Dominique S; Courtois H
    Rev Med Interne; 1999 Nov; 20(11):1017-27. PubMed ID: 10586440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac and pulmonary involvement in scleroderma].
    Launay D; Hachulla E
    Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
    Wells AU; Steen V; Valentini G
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A successful therapy with plasma exchange for interstitial pneumonia of progressive systemic sclerosis.
    Tamura K; Akiyama J; Oono K; Kadowaki S; Shimada T
    Intern Med; 1992 May; 31(5):649-54. PubMed ID: 1504429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.